Zoetis Inc (NYSE:ZTS) has received an average rating of “Buy” from the twenty research firms that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $73.72.
A number of research analysts have recently commented on the stock. BMO Capital Markets set a $78.00 price target on shares of Zoetis and gave the company a “hold” rating in a research report on Monday, January 22nd. Piper Jaffray Companies restated a “buy” rating and set a $86.00 price target on shares of Zoetis in a research report on Thursday, January 18th. Jefferies Group restated a “buy” rating and set a $89.00 price target on shares of Zoetis in a research report on Tuesday, January 16th. Zacks Investment Research downgraded shares of Zoetis from a “hold” rating to a “sell” rating and set a $83.00 price objective for the company. in a report on Saturday, January 13th. Finally, Cantor Fitzgerald set a $85.00 price objective on shares of Zoetis and gave the stock a “buy” rating in a report on Thursday, January 11th.
Several large investors have recently modified their holdings of ZTS. Shelton Capital Management bought a new position in shares of Zoetis during the second quarter valued at about $232,000. Arrowstreet Capital Limited Partnership bought a new position in shares of Zoetis during the second quarter valued at about $917,000. Raymond James Financial Services Advisors Inc. raised its stake in shares of Zoetis by 51.4% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 31,041 shares of the company’s stock valued at $1,936,000 after acquiring an additional 10,539 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Zoetis by 3.9% during the second quarter. Public Employees Retirement System of Ohio now owns 237,680 shares of the company’s stock valued at $14,826,000 after acquiring an additional 9,028 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd increased its position in shares of Zoetis by 7.3% during the second quarter. Dynamic Technology Lab Private Ltd now owns 5,901 shares of the company’s stock valued at $368,000 after buying an additional 401 shares during the period. 93.72% of the stock is owned by hedge funds and other institutional investors.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Stockholders of record on Friday, January 19th will be paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.68%. This is an increase from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Thursday, January 18th. Zoetis’s dividend payout ratio is 26.32%.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.